{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:57:37Z","timestamp":1792796257150,"version":"4.5.0"},"reference-count":175,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Paclitaxel (PTX) has been used for cancer treatment for decades and has become one of the most successful chemotherapeutics in the clinic and financially. However, serious problems with its use still exist, owing to its poor solubility and non-selective toxicity. With respect to these issues, recent advances have addressed the water solubility and tumor specificity related to PTX application. Many measures have been proposed to remedy these limitations by enhancing tumor recognition via ligand-receptor-mediated targeting as well as other associated strategies. In this review, we investigated various kinds of ligands that have emerged as PTX tumor-targeting tools. In particular, this article highlights small molecule-, protein-, and aptamer-functionalized conjugates and nanoparticles (NPs), providing a promising approach for PTX-based individualized treatment prospects.<\/jats:p>","DOI":"10.3389\/fcell.2021.626910","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T01:37:33Z","timestamp":1616981853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy"],"prefix":"10.3389","volume":"9","author":[{"given":"Yuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Chun Fai","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4161\/rna.19718","article-title":"RNA-binding protein nucleolin in disease.","volume":"9","author":"Abdelmohsen","year":"2012","journal-title":"RNA Biol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120789","article-title":"Paclitaxel\u2019s mechanistic and clinical effects on breast cancer.","volume":"9","author":"Abu Samaan","year":"2019","journal-title":"Biomolecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-06-3914","article-title":"Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.","volume":"67","author":"Alexandre","year":"2007","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/jnci\/djj049","article-title":"Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.","volume":"98","author":"Alexandre","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"B5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/978-981-13-7647-4_12","article-title":"ABC transporter-mediated multidrug-resistant cancer.","volume":"1141","author":"Amawi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12645-011-0024-6","article-title":"Aptamer-labeled PLGA nanoparticles for targeting cancer cells.","volume":"3","author":"Aravind","year":"2012","journal-title":"Cancer Nanotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1096\/fj.201700025R","article-title":"Maternofetal transport of vitamin B12: role of TCblR\/CD320 and megalin.","volume":"31","author":"Arora","year":"2017","journal-title":"FASEB J."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/Fimmu.2020.00124","article-title":"The irony of humanization: alemtuzumab, the first, but one of the most immunogenic, humanized monoclonal antibodies.","volume":"11","author":"Baker","year":"2020","journal-title":"Front. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/annonc\/mdq438","article-title":"Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma.","volume":"22","author":"Bedikian","year":"2011","journal-title":"Ann. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijpharm.2017.05.016","article-title":"Paclitaxel: what has been done and the challenges remain ahead.","volume":"526","author":"Bernabeu","year":"2017","journal-title":"Int. J. Pharmaceut."},{"key":"B11","first-page":"130","article-title":"Raf-1\/bcl-2 phosphorylation: a step from microtubule damage to cell death.","volume":"57","author":"Blagosklonny","year":"1997","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/21691401.2018.1470525","article-title":"Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.","volume":"46","author":"Borker","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.vh.2016.08.004","article-title":"Estrogen receptors modulation of anxiety-like behavior.","volume":"103","author":"Borrow","year":"2017","journal-title":"Vitam. Horm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.pharmtox.010909.105547","article-title":"Discovery and development of therapeutic aptamers.","volume":"50","author":"Bouchard","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.7150\/thno.36338","article-title":"CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1\/P50.","volume":"9","author":"Chi","year":"2019","journal-title":"Theranostics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/path.1415","article-title":"Tenascins: regulation and putative functions during pathological stress.","volume":"200","author":"Chiquet-Ehrismann","year":"2003","journal-title":"J. Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000151352","article-title":"Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma.","volume":"54","author":"Christopeit","year":"2008","journal-title":"Chemotherapy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/mp900191s","article-title":"Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.","volume":"7","author":"Collnot","year":"2010","journal-title":"Mol. Pharm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0378-8741(91)90110-Y","article-title":"Can ethnopharmacology contribute to the development of new anticancer drugs.","volume":"32","author":"Cordell","year":"1991","journal-title":"J. Ethnopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5301\/jbm.2008.3270","article-title":"Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.","volume":"23","author":"Decock","year":"2008","journal-title":"Int. J. Biol. Markers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1166\/jbn.2016.2283","article-title":"Superparamagnetic iron oxide nanorod carriers for paclitaxel delivery in the treatment and imaging of colon cancer in mice.","volume":"12","author":"Dehvari","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/cyto.a.22715","article-title":"Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.","volume":"87","author":"Delac","year":"2015","journal-title":"Cytometry A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109121","article-title":"HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.","volume":"117","author":"Duan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv700","article-title":"Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.","volume":"43","author":"Dupont","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1039\/c3nr90022c","article-title":"Development of drug loaded nanoparticles for tumor targeting. Part 2: enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models.","volume":"5","author":"El-Dakdouki","year":"2013","journal-title":"Nanoscale"},{"key":"B26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41419-019-1870-0","article-title":"Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo.","volume":"10","author":"Engelberg","year":"2019","journal-title":"Cell Death Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ijpharm.2016.10.066","article-title":"Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.","volume":"515","author":"Esfandyari-Manesh","year":"2016","journal-title":"Int. J. Pharm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1039\/c9tb02818h","article-title":"Glutathione-sensitive and folate-targeted nanoparticles loaded with paclitaxel to enhance oral squamous cell carcinoma therapy.","volume":"8","author":"Fan","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"B29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41416-019-0391-z","article-title":"A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.","volume":"120","author":"Fujiwara","year":"2019","journal-title":"Brit. J. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1517\/13543784.2011.576666","article-title":"Paclitaxel poliglumex for ovarian cancer.","volume":"20","author":"Galic","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.2147\/IJN.S165184","article-title":"Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma.","volume":"13","author":"Ganipineni","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2928507","article-title":"Targeted delivery of paclitaxel in liver cancer using hyaluronic acid functionalized mesoporous hollow alumina nanoparticles.","volume":"2019","author":"Gao","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"31458","DOI":"10.1021\/acsami.7b08969","article-title":"Intraorgan targeting of gold conjugates for precise liver cancer treatment.","volume":"9","author":"Gao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2018.12.022","article-title":"Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice.","volume":"294","author":"Garofalo","year":"2019","journal-title":"J. Control Release"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1021\/Jo00093a040","article-title":"Samarium diiodide-mediated deoxygenation of taxol - a one-step synthesis of 10-deacetoxytaxol.","volume":"59","author":"Georg","year":"1994","journal-title":"J. Org. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1021\/Jm00100a031","article-title":"Synthesis of biologically-active taxol analogs with modified phenylisoserine side-chains.","volume":"35","author":"Georg","year":"1992","journal-title":"J. Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/sj.onc.1204487","article-title":"Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1\/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.","volume":"20","author":"Giannakakou","year":"2001","journal-title":"Oncogene"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.201800348","article-title":"Effect of the folate ligand density on the targeting property of folated-conjugated polymeric nanoparticles.","volume":"19","author":"Gong","year":"2019","journal-title":"Macromol. Biosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.msec.2018.05.054","article-title":"Paclitaxel loaded vitamin E-TPGS nanoparticles for cancer therapy.","volume":"91","author":"Gorain","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","article-title":"The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions.","volume":"76","author":"Gornstein","year":"2014","journal-title":"Neuropharmacology"},{"key":"B41","first-page":"694","article-title":"Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.","volume":"61","author":"Guillemard","year":"2001","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1021\/Jo982095h","article-title":"Synthesis and biological evaluation of novel paclitaxel (Taxol) D-ring modified analogues.","volume":"64","author":"Gunatilaka","year":"1999","journal-title":"J. Org. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2217\/nnm-2018-0321","article-title":"Vitamin B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance.","volume":"14","author":"Guo","year":"2019","journal-title":"Nanomedicine (Lond)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ajps.2018.08.009","article-title":"Redox-sensitive micelles for targeted intracellular delivery and combination chemotherapy of paclitaxel and all-trans-retinoid acid.","volume":"14","author":"Han","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00001813-199204000-00008","article-title":"Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.","volume":"3","author":"Hanauske","year":"1992","journal-title":"Anticancer Drugs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s00018-005-5330-x","article-title":"Understanding microtubule dynamics for improved cancer therapy.","volume":"62","author":"Honore","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40259-018-0299-9","article-title":"Expanding the boundaries of biotherapeutics with bispecific antibodies.","volume":"32","author":"Husain","year":"2018","journal-title":"Biodrugs"},{"key":"B48","first-page":"1038","article-title":"Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.","volume":"8","author":"Ibrahim","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2282","article-title":"nab-Paclitaxel (Abraxane (R)): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors.","volume":"11","author":"Iglesias","year":"2009","journal-title":"Breast Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-016-3736-9","article-title":"Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II\/III study.","volume":"156","author":"Jain","year":"2016","journal-title":"Breast Cancer Res. Treat"},{"key":"B51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/aps.2016.105","article-title":"Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase.","volume":"38","author":"Jang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/jps.23928","article-title":"Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.","volume":"103","author":"Jiang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"B53","first-page":"816","article-title":"Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.","volume":"56","author":"Jordan","year":"1996","journal-title":"Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jmr.2012.12.010","article-title":"NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: fatty acids influence the HSA-metabolite interaction.","volume":"228","author":"Jupin","year":"2013","journal-title":"J. Magn. Reson."},{"key":"B55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents.","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/onc.2015.152","article-title":"Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.","volume":"35","author":"Khongkow","year":"2016","journal-title":"Oncogene"},{"key":"B57","first-page":"A35","article-title":"Integrated microfluidic platform for multiplex selex on a chip.","volume":"21","author":"Kim","year":"2011","journal-title":"Nucleic Acid Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0167-7799(94)90120-1","article-title":"Taxol - the chemistry and structure-activity-relationships of a novel anticancer agent.","volume":"12","author":"Kingston","year":"1994","journal-title":"Trends Biotechnol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/or.2014.3210","article-title":"Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.","volume":"32","author":"Kinoshita","year":"2014","journal-title":"Oncol. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4062\/biomolther.2013.085","article-title":"Nucleic acid aptamers: new methods for selection, stabilization, and application in biomedical science.","volume":"21","author":"Kong","year":"2013","journal-title":"Biomol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.bmcl.2005.10.089","article-title":"Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents.","volume":"16","author":"Kuznetsova","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1535-7163.MCT-17-0682","article-title":"Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting.","volume":"17","author":"Layek","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.msec.2018.02.006","article-title":"Advances in thermosensitive polymer-grafted platforms for biomedical applications.","volume":"92","author":"Le","year":"2018","journal-title":"Mat. Sci. Eng. C Mater."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1021\/acs.biomac.8b00189","article-title":"Bilirubin nanoparticle-assisted delivery of a small molecule-drug conjugate for targeted cancer therapy.","volume":"19","author":"Lee","year":"2018","journal-title":"Biomacromolecules"},{"key":"B65","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/10717544.2019.1580797","article-title":"Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.","volume":"26","author":"Lei","year":"2019","journal-title":"Drug Deliv."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41467-017-01565-6","article-title":"A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer.","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.1021\/acsnano.9b04166","article-title":"Chondroitin sulfate-linked prodrug nanoparticles target the golgi apparatus for cancer metastasis treatment.","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103132","article-title":"Amphiphilic polymeric micelles based on deoxycholic acid and folic acid modified chitosan for the delivery of paclitaxel.","volume":"19","author":"Li","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejps.2018.07.055","article-title":"PH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.","volume":"124","author":"Li","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.2147\/IJN.S67343","article-title":"Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.","volume":"9","author":"Li","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1080\/10717544.2017.1373167","article-title":"Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG-PCCL-modified magnetic iron oxide nanoparticles.","volume":"24","author":"Li","year":"2017","journal-title":"Drug Deliv."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119576","article-title":"Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.","volume":"586","author":"Li","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejps.2018.02.021","article-title":"Paclitaxel controlled delivery using a pH-responsive functional-AuNP\/block-copolymer vesicular nanocarrier composite system.","volume":"117","author":"Liaskoni","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B74","first-page":"60","article-title":"Phylogenetic diversification of immunoglobulin genes and the antibody repertoire.","volume":"10","author":"Litman","year":"1993","journal-title":"Mol. Biol. Evol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1021\/acs.analchem.9b00609","article-title":"Identification of vigilin as a potential ischemia biomarker by brain slice-based systematic evolution of ligands by exponential enrichment.","volume":"91","author":"Liu","year":"2019","journal-title":"Anal. Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1177\/0885328220905256","article-title":"Tumor-targeting and redox-sensitive micelles based on hyaluronic acid conjugate for delivery of paclitaxel.","volume":"34","author":"Liu","year":"2020","journal-title":"J. Biomater. Appl."},{"key":"B77","first-page":"2039","article-title":"Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-x(L) and bak expression.","volume":"3","author":"Liu","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1021\/acs.molpharmaceut.6b00870","article-title":"CD44 receptor targeting and endosomal pH-sensitive dual functional hyaluronic acid micelles for intracellular paclitaxel delivery.","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"key":"B79","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrm3888","article-title":"Signalling dynamics in the spindle checkpoint response.","volume":"15","author":"London","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110038","article-title":"In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy.","volume":"105","author":"Luiz","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119870","article-title":"Multifunctional composite nanoparticles based on hyaluronic acid-paclitaxel conjugates for enhanced cancer therapy.","volume":"589","author":"Luo","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.12.032","article-title":"Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts.","volume":"391","author":"Luo","year":"2017","journal-title":"Cancer Lett."},{"key":"B83","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1021\/acsami.5b11471","article-title":"Hyaluronic acid-modified multifunctional Q-graphene for targeted killing of drug-resistant lung cancer cells.","volume":"8","author":"Luo","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B84","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jcis.2016.12.004","article-title":"Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-gamma-glutamylglutamine)-paclitaxel nanoconjugates.","volume":"490","author":"Luo","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8526190","article-title":"Folate-functionalized mesoporous hollow SnO2 nanofibers as a targeting drug carrier to improve the antitumor effect of paclitaxel for liver cancer therapy.","volume":"2018","author":"Lv","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2147\/Ott.S40947","article-title":"Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review.","volume":"7","author":"Marchetti","year":"2014","journal-title":"Oncotargets Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jama.2020.10245","article-title":"Monoclonal antibodies for prevention and treatment of COVID-19.","volume":"324","author":"Marovich","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"B88","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1517\/14740338.6.5.609","article-title":"Paclitaxel: a review of adverse toxicities and novel delivery strategies.","volume":"6","author":"Marupudi","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"B89","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1208\/s12248-014-9710-8","article-title":"Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.","volume":"17","author":"Mccombs","year":"2015","journal-title":"AAPS J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.1021\/ja052406n","article-title":"In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis.","volume":"127","author":"Mendonsa","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"B91","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11033-018-4467-2","article-title":"Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting.","volume":"46","author":"Mie","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/srep23489","article-title":"Paclitaxel-loaded phosphonated calixarene nanovesicles as a modular drug delivery platform.","volume":"6","author":"Mo","year":"2016","journal-title":"Sci. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1021\/acs.jmedchem.7b00527","article-title":"Aptamer functionalization of nanosystems for glioblastoma targeting through the blood-brain barrier.","volume":"60","author":"Monaco","year":"2017","journal-title":"J. Med. Chem."},{"key":"B94","first-page":"107","article-title":"AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.","volume":"12","author":"Mongelard","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/wnl.46.1.108","article-title":"Peripheral neuropathy secondary to docetaxel (Taxotere).","volume":"46","author":"New","year":"1996","journal-title":"Neurology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent progress in aptamer discoveries and modifications for therapeutic applications.","volume":"8","author":"Ni","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1021\/Ja00114a005","article-title":"Chemical synthesis and biological evaluation of C-2 taxoids.","volume":"117","author":"Nicolaou","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"B98","doi-asserted-by":"publisher","first-page":"15010","DOI":"10.1021\/ja5079464","article-title":"Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells.","volume":"136","author":"Oh","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"B99","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1021\/ar700093f","article-title":"Guided molecular missiles for tumor-targeting chemotherapy-case studies using the second-generation taxolds as warheads.","volume":"41","author":"Ojima","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1021\/jm025540g","article-title":"Tumor-specific novel taxoid-monoclonal antibody conjugates.","volume":"45","author":"Ojima","year":"2002","journal-title":"J. Med. Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4155\/Fmc.11.167","article-title":"Tumor-targeting drug delivery of new-generation taxoids.","volume":"4","author":"Ojima","year":"2012","journal-title":"Future Med. Chem."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/Smll.201703670","article-title":"A comparative in vivo study of albumin-coated paclitaxel nanocrystals and abraxane.","volume":"14","author":"Park","year":"2018","journal-title":"Small"},{"key":"B103","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.","volume":"192","author":"Pascucci","year":"2014","journal-title":"J. Control Release"},{"key":"B104","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/mp800024g","article-title":"Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.","volume":"5","author":"Platt","year":"2008","journal-title":"Mol. Pharm."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/srep11760","article-title":"Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression.","volume":"5","author":"Puvvada","year":"2015","journal-title":"Sci. Rep."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115498","article-title":"Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment.","volume":"229","author":"Qu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"B107","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/jm900899g","article-title":"Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy.","volume":"53","author":"Quiles","year":"2010","journal-title":"J. Med. Chem."},{"key":"B108","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1158\/0008-5472.CAN-05-1162","article-title":"Resistance to paclitaxel is proportional to cellular total antioxidant capacity.","volume":"65","author":"Ramanathan","year":"2005","journal-title":"Cancer Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.","volume":"229","author":"Ravar","year":"2016","journal-title":"J. Control Release"},{"key":"B110","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2.","volume":"155","author":"R\u00e9gina","year":"2008","journal-title":"Brit. J. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10637-013-0045-6","article-title":"A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.","volume":"32","author":"Rosenberg","year":"2014","journal-title":"Invest. New Drugs"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/jnci\/82.15.1247","article-title":"Taxol: a novel investigational antimicrotubule agent.","volume":"82","author":"Rowinsky","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"B113","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol.","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jconrel.2012.05.013","article-title":"Multifunctional drug delivery system for targeting tumor and its acidic microenvironment.","volume":"161","author":"Shen","year":"2012","journal-title":"J. Control Release"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102061","article-title":"Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier.","volume":"21","author":"Shi","year":"2019","journal-title":"Nanomedicine"},{"key":"B116","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jphotobiol.2013.06.015","article-title":"A fluorescent spectroscopy and modelling analysis of anti-heparanase aptamers-serum protein interactions.","volume":"127","author":"Silva","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"key":"B117","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2005.09.033","article-title":"Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.","volume":"109","author":"Singer","year":"2005","journal-title":"J. Control Release"},{"key":"B118","first-page":"285","article-title":"Facilitative glucose transporter expression in human cancer tissue.","volume":"56","author":"Smith","year":"1999","journal-title":"Br. J. Biomed. Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0955-0674(97)80081-6","article-title":"Coupling cell division and cell death to microtubule dynamics.","volume":"9","author":"Sorger","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","article-title":"Ligand-targeted drug delivery.","volume":"117","author":"Srinivasarao","year":"2017","journal-title":"Chem. Rev."},{"key":"B121","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00216-005-3388-9","article-title":"FluMag-SELEX as an advantageous method for DNA aptamer selection.","volume":"383","author":"Stoltenburg","year":"2005","journal-title":"Anal. Bioanal. Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"38700","DOI":"10.1021\/acsami.8b11349","article-title":"On-demand versatile prodrug nanomicelle for tumor-specific bioimaging and photothermal-chemo synergistic cancer therapy.","volume":"10","author":"Su","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B123","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1039\/c5an01995h","article-title":"Aptamers: versatile molecular recognition probes for cancer detection.","volume":"141","author":"Sun","year":"2016","journal-title":"Analyst"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1080\/10717544.2018.1494225","article-title":"Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.","volume":"25","author":"Sun","year":"2018","journal-title":"Drug Deliv."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/Ijms20133331","article-title":"The clinical potential of oligonucleotide therapeutics against pancreatic cancer.","volume":"20","author":"Takakura","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B126","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1200\/jco.2006.24.18_suppl.2017","article-title":"Results of a clinical pharmacokinetic (PK) bioequiulence (BE) study of liposomal paclitaxel (LEP-ETU) versus paclitaxel (T) in patients with advanced cancer.","volume":"24","author":"Tan","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118806","article-title":"Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.","volume":"573","author":"Tang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ab884d","article-title":"Construction and evaluation of hyaluronic acid-based copolymers as a targeted chemotherapy drug carrier for cancer therapy.","volume":"31","author":"Tang","year":"2020","journal-title":"Nanotechnology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijbiomac.2014.08.054","article-title":"Paclitaxel loaded hyaluronic acid nanoparticles for targeted cancer therapy: in vitro and in vivo analysis.","volume":"72","author":"Thomas","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1166\/jbn.2014.1660","article-title":"Biodistribution and pharmacokinetics in rats and antitumor effect in various types of tumor-bearing mice of novel self-assembled gelatin-oleic acid nanoparticles containing paclitaxel.","volume":"10","author":"Tran","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"12960","DOI":"10.1021\/acsami.7b19109","article-title":"Anisamide-anchored lyotropic nano-liquid crystalline particles with AIE effect: a smart optical beacon for tumor imaging and therapy.","volume":"10","author":"Urandur","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B132","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1758834015584763","article-title":"Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.","volume":"7","author":"Vergote","year":"2015","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1021\/jm5019115","article-title":"Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugates.","volume":"58","author":"Vineberg","year":"2015","journal-title":"J. Med. Chem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.biopha.2018.12.008","article-title":"Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier.","volume":"110","author":"Vinothini","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B135","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1016\/S0040-4020(01)91208-6","article-title":"Rearrangement reactions of taxanes - structural modifications of 10-deacetylbaccatin-III.","volume":"48","author":"Wahl","year":"1992","journal-title":"Tetrahedron"},{"key":"B136","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biopha.2018.06.137","article-title":"RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.","volume":"106","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-37","article-title":"Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"B138","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1174-9","article-title":"Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. the isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.","volume":"93","author":"Wani","year":"1971","journal-title":"J. Am. Chem. Soc."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.E14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells.","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"B141","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1247\/Csf.24.329","article-title":"Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.","volume":"24","author":"Wilson","year":"1999","journal-title":"Cell Struct. Funct."},{"key":"B142","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.msec.2015.04.012","article-title":"Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model.","volume":"53","author":"Wu","year":"2015","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"B143","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1021\/mp300686g","article-title":"Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.","volume":"10","author":"Wu","year":"2013","journal-title":"Mol. Pharm."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1021\/acs.biomac.6b00380","article-title":"Vitamin E-oligo(methyl diglycol l-glutamate) as a biocompatible and functional surfactant for facile preparation of active tumor-targeting PLGA nanoparticles.","volume":"17","author":"Wu","year":"2016","journal-title":"Biomacromolecules"},{"key":"B145","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.2147\/Ijn.S136032","article-title":"Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer.","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.925583","article-title":"A PD-L1 aptamer selected by loss-gain cell-SELEX conjugated with paclitaxel for treating triple-negative breast cancer.","volume":"26","author":"Wu","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1208\/s12249-018-1070-8","article-title":"Co-delivery of metformin and paclitaxel via folate-modified pH-sensitive micelles for enhanced anti-tumor efficacy.","volume":"19","author":"Xiao","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.addr.2010.07.009","article-title":"Nanoparticle-based theranostic agents.","volume":"62","author":"Xie","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.7150\/thno.41228","article-title":"Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"B150","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.canlet.2012.07.002","article-title":"Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.","volume":"334","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2020.104882","article-title":"Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.","volume":"228","author":"Yang","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/Ijms17020194","article-title":"Methods to design and synthesize antibody-drug conjugates (ADCs).","volume":"17","author":"Yao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0700-z","article-title":"Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.","volume":"37","author":"Yao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.fct.2012.11.004","article-title":"Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.","volume":"52","author":"Ye","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.e13538","article-title":"Evaluation of the toxicity and efficacy of paclitaxel nanoencapsulated with polyethyloxazoline polymers.","volume":"31","author":"Yin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.actbio.2015.08.029","article-title":"Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.","volume":"26","author":"Yin","year":"2015","journal-title":"Acta Biomater."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024077","article-title":"Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1166\/jbn.2019.2751","article-title":"Co-delivery of paclitaxel and PLK1-targeted siRNA using aptamer-functionalized cationic liposome for synergistic anti-breast cancer effects in vivo.","volume":"15","author":"Yu","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030351","article-title":"Development of DNA aptamers to native EpCAM for isolation of lung circulating tumor cells from human blood.","volume":"11","author":"Zamay","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B160","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1021\/acsami.8b19798","article-title":"A CD44-targeting programmable drug delivery system for enhancing and sensitizing chemotherapy to drug-resistant cancer.","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118595","article-title":"Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6.","volume":"569","author":"Zhang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"B162","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/10717544.2020.1770373","article-title":"Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel\/apatinib effectively reverse cancer multidrug resistance.","volume":"27","author":"Zhang","year":"2020","journal-title":"Drug Deliv."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1208\/s12248-014-9651-2","article-title":"Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.","volume":"16","author":"Zhang","year":"2014","journal-title":"AAPS J."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2480-8","article-title":"Hyaluronic acid layer-by-layer (LbL) nanoparticles for synergistic chemo-phototherapy.","volume":"35","author":"Zhao","year":"2018","journal-title":"Pharm. Res."},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ab055f","article-title":"Polydopamine-based surface modification of paclitaxel nanoparticles for osteosarcoma targeted therapy.","volume":"30","author":"Zhao","year":"2019","journal-title":"Nanotechnology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejpb.2012.03.004","article-title":"Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.","volume":"81","author":"Zhao","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1039\/b904476k","article-title":"Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells.","volume":"134","author":"Zhao","year":"2009","journal-title":"Analyst"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2147\/IJN.S157082","article-title":"The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.","volume":"13","author":"Zheng","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1021\/acs.molpharmaceut.9b01148","article-title":"Folic acid-modified nanoerythrocyte for codelivery of paclitaxel and tariquidar to overcome breast cancer multidrug resistance.","volume":"17","author":"Zhong","year":"2020","journal-title":"Mol. Pharm."},{"key":"B170","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biomaterials.2016.01.049","article-title":"Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.","volume":"84","author":"Zhong","year":"2016","journal-title":"Biomaterials"},{"key":"B171","doi-asserted-by":"publisher","first-page":"76628","DOI":"10.18632\/oncotarget.10532","article-title":"SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple-negative breast cancer.","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"B172","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.actbio.2017.06.017","article-title":"Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.","volume":"58","author":"Zhu","year":"2017","journal-title":"Acta Biomater."},{"key":"B173","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ejmech.2018.12.035","article-title":"Small molecule-drug conjugates: a novel strategy for cancer-targeted treatment.","volume":"163","author":"Zhuang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B174","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cell.2019.05.035","article-title":"The cytoplasmic DNA sensor cGAS promotes mitotic cell death.","volume":"178","author":"Zierhut","year":"2019","journal-title":"Cell"},{"key":"B175","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1080\/21691401.2019.1626863","article-title":"Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.","volume":"47","author":"Zou","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.626910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T01:37:41Z","timestamp":1616981861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.626910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":175,"alternative-id":["10.3389\/fcell.2021.626910"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.626910","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"article-number":"626910"}}